Management


Cascade Biotechnology INC | Complement Therapeutics; novel approach to CNS/PNS disease management using the innate complement system.

Daniel Benjamin Ph.D.

Chief Executive Officer

Edwin Holland B.A.

Chief Operating Officer, V.P. Business Development

David Frizinger Ph.D.

Chief Biotechnology Officer

Duncan Taylor Ph.D.

Consultant to Business Development